Biolase Inc (NASDAQ: BIOL) on Friday, plunged -5.09% from the previous trading day, before settling in for the closing price of $0.15. Within the past 52 weeks, BIOL’s price has moved between $0.13 and $47.10.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 7.86% over the last five years. The company achieved an average annual earnings per share of 98.91%. With a float of $31.21 million, this company’s outstanding shares have now reached $32.52 million.
The firm has a total of 157 workers. Let’s measure their productivity.
Biolase Inc (BIOL) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Biolase Inc is 4.05%, while institutional ownership is 4.58%.
Biolase Inc (BIOL) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 4.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 98.91% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.00% during the next five years compared to 59.23% growth over the previous five years of trading.
Biolase Inc (NASDAQ: BIOL) Trading Performance Indicators
Biolase Inc (BIOL) is currently performing well based on its current performance indicators. A quick ratio of 0.68 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -38.01, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.11 in one year’s time.
Technical Analysis of Biolase Inc (BIOL)
Analysing the last 5-days average volume posted by the [Biolase Inc, BIOL], we can find that recorded value of 1.82 million was lower than the volume posted last year of 4.94 million. As of the previous 9 days, the stock’s Stochastic %D was 14.35%. Additionally, its Average True Range was 0.02.
During the past 100 days, Biolase Inc’s (BIOL) raw stochastic average was set at 0.95%, which indicates a significant decrease from 2.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 118.19% in the past 14 days, which was lower than the 199.78% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2170, while its 200-day Moving Average is $2.3803. Now, the first resistance to watch is $0.1471. This is followed by the second major resistance level at $0.1523. The third major resistance level sits at $0.1557. If the price goes on to break the first support level at $0.1385, it is likely to go to the next support level at $0.1351. Now, if the price goes above the second support level, the third support stands at $0.1299.
Biolase Inc (NASDAQ: BIOL) Key Stats
Market capitalization of the company is 4.61 million based on 32,523K outstanding shares. Right now, sales total 49,160 K and income totals -20,630 K. The company made 13,490 K in profit during its latest quarter, and -5,330 K in sales during its previous quarter.
